SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-19-054119
Filing Date
2019-02-27
Accepted
2019-02-27 16:32:07
Documents
71
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d678830d10k.htm 10-K 1056756
2 EX-10.9 d678830dex109.htm EX-10.9 63478
3 EX-10.16 d678830dex1016.htm EX-10.16 37504
4 EX-23.1 d678830dex231.htm EX-23.1 4096
5 EX-31.1 d678830dex311.htm EX-31.1 6915
6 EX-31.2 d678830dex312.htm EX-31.2 7064
7 EX-32.1 d678830dex321.htm EX-32.1 4588
14 GRAPHIC g678830g67o17.jpg GRAPHIC 126299
  Complete submission text file 0001193125-19-054119.txt   5178231

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT itci-20181231.xml EX-101.INS 879717
9 XBRL TAXONOMY EXTENSION SCHEMA itci-20181231.xsd EX-101.SCH 46779
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20181231_cal.xml EX-101.CAL 70332
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20181231_def.xml EX-101.DEF 176230
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20181231_lab.xml EX-101.LAB 442765
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20181231_pre.xml EX-101.PRE 323530
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36274 | Film No.: 19638189
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences